Primary reconstruction of mandible in head and neck cancer with silastic implant--a review of 69 cases.
Different methods of primary mandibular reconstruction carried out at the Tata Memorial Cancer Hospital range from the pectoralis major myocutaneous or osteomyocutaneous composite flap, which is the most frequently performed procedure, to a free vascularised composite tissue transfer with microvascular anastomosis, including, iliac crest free vascularised bone grafts or radial artery forearm flap free vascularised radius bone grafts, free vascularised fibular bone grafts and silastic mandibular implants. The clinical results of immediate mandibular reconstruction with a silastic mandibular implant (SMI) in 69 patients is presented. Out of the 69 cases, 2 patients died in the early post-operative period. Twenty (30%) SMI were retained for a period of 1 year to 5 years. Forty seven (70%) SMI were retained for a period of less than 1 year. These implants have been used in a variety of cases, with or without major flap reconstruction, where a skeletal support was indicated, especially after mandibular arch resection. The results of this series indicates the importance of these implants as a short term spacer, even in advanced, fungating lesions of head and neck cancer where the risk of infection, haematoma and salivary leak is very high. Bone replacements were undertaken at a later date in suitable cases. The effects of preoperative chemotherapy and radiotherapy on the retention of these implants has also been studied.
Bhathena
H M
HM
Tata Memorial Hospital, Plastic and Reconstructive Surgery Department, Parel, Mumbai (Bombay), India.
Kavarana
N M
NM
D002294:Carcinoma, Squamous Cell / Q000601:surgery*; D006801:Humans; D008339:Mandibular Neoplasms / Q000601:surgery*; D019930:Mandibular Prosthesis Implantation; D012189:Retrospective Studies; D012826:Silicone Elastomers / Q000627:therapeutic use*; D016896:Treatment Outcome
D012826:Silicone Elastomers